Soon-Shiong invests in Toumaz; Cellnovo gets $48M to go global with diabetes management system;

> Mobile healthcare cheerleader (and angel investor) Dr. Patrick Soon-Shiong's firm, California Capital Equity, just purchased a more than 2 percent stake in wireless technology developer Toumaz of London. It may signal the beginning of a long-term play by Soon-Shiong, who just last week snapped up Vitality, the maker of the GlowCaps medication management system. Article 

> Clinical decision-support developer PEPID is launching a new iPad version of its application at HIMSS11. The app includes a drug database, dosage calculators, drug-interaction software and a symptom checker. Press release 

> Sherwin Krug, the CEO who just sold his company, to Healthagen, has already debuted a new company--TheDocClock. It allows patients to log and track wait times in physician offices and emergency rooms. Website  

> Cellnovo just received $48 million to go global with its mobile diabetes management system. The system consists of an insulin pump, mobile handset and diabetes management website for users. Article 

> Wondering if Lexi-Comp's iPad app is worth the nearly $300 annual price tag? iMedicalApps did an in-depth review and said overall, "yes." Post 

And Finally... Hopefully nobody had morning breath. Article